Suchergebnisse - Busaidy, Naifa
- Treffer 1 - 20 von 57
- Zur nächsten Seite
-
1
The Year in Medical Thyroidology Review: Current Challenges and Future Directions von Busaidy, Naifa Lamki
Veröffentlicht 2020Text -
2
-
3
-
4
-
5
Larotrectinib Before Initial Radioactive Iodine Therapy in Pediatric TRK Fusion–Positive Papillary Thyroid Carcinoma: Time to Reconsider the Treatment Paradigm for Distantly Metast... von Waguespack, Steven G., Tewari, Sanjit O., Busaidy, Naifa L., Zafereo, Mark E.
Veröffentlicht 2022Text -
6
Safe and Effective Dosing of Basal–Bolus Insulin in Patients Receiving High-Dose Steroids for Hyper-Cyclophosphamide, Doxorubicin, Vincristine, and Dexamethasone Chemotherapy von Brady, Veronica, Thosani, Sonali, Zhou, Shouhou, Bassett, Roland, Busaidy, Naifa Lamki, Lavis, Victor
Veröffentlicht 2014Text -
7
-
8
OR27-6 Combination Vemurafenib (BRAF Inhibitor)/Cobimetinib (MEK Inhibitor)/Atezolizumab (Anti-PDL1 Inhibitor) in BRAF-V600E Mutated Anaplastic Thyroid Cancer (ATC): Initial Safety... von Cabanillas, Maria, Busaidy, Naifa, Dadu, Ramona, Ferrarotto, Renata, Gross, Neil, Gule-Monroe, Maria, Lu, Charles, Grosu, Horiana, Williams, Michelle, Zafereo, Mark
Veröffentlicht 2019Text -
9
Management of Metabolic Effects Associated With Anticancer Agents Targeting the PI3K-Akt-mTOR Pathway von Busaidy, Naifa L., Farooki, Azeez, Dowlati, Afshin, Perentesis, John P., Dancey, Janet E., Doyle, Laurence A., Brell, Joanna M., Siu, Lillian L.
Veröffentlicht 2012Text -
10
Efficacy of the Natural Clay, Calcium Aluminosilicate Anti-Diarrheal, in Reducing Medullary Thyroid Cancer–Related Diarrhea and Its Effects on Quality of Life: A Pilot Study von Dadu, Ramona, Hu, Mimi I., Cleeland, Charles, Busaidy, Naifa L., Habra, Mouhammed, Waguespack, Steven G., Sherman, Steven I., Ying, Anita, Fox, Patricia, Cabanillas, Maria E.
Veröffentlicht 2015Text -
11
Phase I Clinical Trials in 56 Patients with Thyroid Cancer: The M. D. Anderson Cancer Center Experience von Tsimberidou, Apostolia Maria, Vaklavas, Christos, Wen, Sijin, Hong, David, Wheler, Jennifer, Ng, Chaan, Naing, Aung, Tse, Susan, Busaidy, Naifa, Markman, Maurie, Sherman, Steven I., Kurzrock, Razelle
Veröffentlicht 2009Text -
12
Cushing's syndrome secondary to ectopic ACTH secretion: The University of Texas MD Anderson Cancer Center Experience von Ejaz, Shamim, Vassilopoulou-Sellin, Rena, Busaidy, Naifa L., Hu, Mimi I., Waguespack, Steven G., Jimenez, Camilo, Ying, Anita K., Cabanillas, Maria, Abbara, Maher, Habra, Mouhammed Amir
Veröffentlicht 2011Text -
13
-
14
Acquired Secondary RAS Mutation in BRAF(V600E)-Mutated Thyroid Cancer Patients Treated with BRAF Inhibitors von Cabanillas, Maria E., Dadu, Ramona, Iyer, Pryianka, Wanland, Kacey B., Busaidy, Naifa L., Ying, Anita, Gule-Monroe, Maria, Wang, Jennifer R., Zafereo, Mark, Hofmann, Marie-Claude
Veröffentlicht 2020Text -
15
Adjuvant External Beam Radiotherapy in Locally Advanced Differentiated Thyroid Cancer von Tam, Samantha, Amit, Moran, Boonsripitayanon, Mongkol, Cabanillas, Maria E., Busaidy, Naifa L., Gunn, G. Brandon, Lai, Stephen Y., Gross, Neil D., Sturgis, Erich M., Zafereo, Mark E.
Veröffentlicht 2017Text -
16
Association of Lymph Node Density With Survival of Patients With Papillary Thyroid Cancer von Amit, Moran, Tam, Samantha, Boonsripitayanon, Mongkol, Cabanillas, Maria E., Busaidy, Naifa L., Grubbs, Elizabeth Gardner, Lai, Stephen Y., Gross, Neil D., Sturgis, Erich M., Zafereo, Mark E.
Veröffentlicht 2017Text -
17
-
18
Targeted Therapy in Advanced Thyroid Cancer to Resensitize Tumors to Radioactive Iodine von Jaber, Tania, Waguespack, Steven G, Cabanillas, Maria E, Elbanan, Mohamed, Vu, Thinh, Dadu, Ramona, Sherman, Steven I, Amit, Moran, Santos, Elmer B, Zafereo, Mark, Busaidy, Naifa L
Veröffentlicht 2018Text -
19
MON-LB097 The Genomic Landscape of Preoperative FNAs Positive for the Afirma GSC Medullary Thyroid Cancer Classifier von Waguespack, Steven, Busaidy, Naifa, Hu, Mimi, Grubbs, Elizabeth, Weitzman, Steven, Wirth, Lori, Zafereo, Mark, Babiarz, Joshua, Hao, Yangyang, Huang, Jing, Kennedy, Giulia, Walsh, P. Sean, Kloos, Richard
Veröffentlicht 2019Text -
20
Efficacy and Tolerability of Different Starting Doses of Sorafenib in Patients With Differentiated Thyroid Cancer von Dadu, Ramona, Waguespack, Steven G., Sherman, Steven I., Hu, Mimi I., Busaidy, Naifa L., Jimenez, Camilo, Habra, Mohammed A., Ying, Anita K., Bassett, Roland L., Cabanillas, Maria E.
Veröffentlicht 2014Text